Registration Dossier
Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 500-107-7 | CAS number: 40039-93-8
Toxicological information
Toxicological Summary
Currently viewing:
Administrative data
Workers - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 7 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 300
- Modified dose descriptor starting point:
- NOAEC
- Value:
- 2 100 mg/m³
- Explanation for the modification of the dose descriptor starting point:
No inhalation study available
- AF for dose response relationship:
- 1
- Justification:
- REACH Guidance Table R.8-6
- AF for differences in duration of exposure:
- 6
- Justification:
- REACH Guidance Table R.8-6-subacute to chronic
- AF for interspecies differences (allometric scaling):
- 4
- Justification:
- REACH Guidance Table R.8-6-rat
- AF for other interspecies differences:
- 2.5
- Justification:
- REACH Guidance Table R.8-6
- AF for intraspecies differences:
- 5
- Justification:
- REACH Guidance Table R.8-6
- AF for the quality of the whole database:
- 1
- Justification:
- REACH Guidance Table R.8-6v
- AF for remaining uncertainties:
- 1
- Justification:
- REACH Guidance Table R.8-6
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Workers - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 1 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 300
- Modified dose descriptor starting point:
- NOAEL
- Value:
- 300 mg/kg bw/day
- Explanation for the modification of the dose descriptor starting point:
- No dermal study available
- AF for dose response relationship:
- 1
- Justification:
- REACH Guidance Table R.8-6
- AF for differences in duration of exposure:
- 6
- Justification:
- REACH Guidance Table R.8-6-subacute to chronic
- AF for interspecies differences (allometric scaling):
- 4
- Justification:
- REACH Guidance Table R.8-6-rat
- AF for other interspecies differences:
- 2.5
- Justification:
- REACH Guidance Table R.8-6
- AF for intraspecies differences:
- 5
- Justification:
- REACH Guidance Table R.8-6
- AF for the quality of the whole database:
- 1
- Justification:
- REACH Guidance Table R.8-6
- AF for remaining uncertainties:
- 1
- Justification:
- REACH Guidance Table R.8-6
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
Workers - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- no hazard identified
Additional information - workers
General Population - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 3.5 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 600
- Modified dose descriptor starting point:
- NOAEC
- Value:
- 2 100 mg/m³
- Explanation for the modification of the dose descriptor starting point:
- No inhalation study available
- AF for dose response relationship:
- 1
- Justification:
- REACH Guidance Table R.8-6
- AF for differences in duration of exposure:
- 6
- Justification:
- REACH Guidance Table R.8-6-subacute to chronic
- AF for interspecies differences (allometric scaling):
- 4
- Justification:
- REACH Guidance Table R.8-6-rat
- AF for other interspecies differences:
- 2.5
- Justification:
- REACH Guidance Table R.8-6
- AF for intraspecies differences:
- 10
- Justification:
- REACH Guidance Table R.8-6
- AF for the quality of the whole database:
- 1
- Justification:
- REACH Guidance Table R.8-6
- AF for remaining uncertainties:
- 1
- Justification:
- REACH Guidance Table R.8-6
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
General Population - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.5 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 600
- Modified dose descriptor starting point:
- NOAEL
- Value:
- 300 mg/kg bw/day
- Explanation for the modification of the dose descriptor starting point:
- No dermal study available
- AF for dose response relationship:
- 1
- Justification:
- REACH Guidance Table R.8-6
- AF for differences in duration of exposure:
- 6
- Justification:
- REACH Guidance Table R.8-6-subacute to chronic
- AF for interspecies differences (allometric scaling):
- 4
- Justification:
- REACH Guidance Table R.8-6-rat
- AF for other interspecies differences:
- 2.5
- Justification:
- REACH Guidance Table R.8-6
- AF for intraspecies differences:
- 10
- Justification:
- REACH Guidance Table R.8-6
- AF for the quality of the whole database:
- 1
- Justification:
- REACH Guidance Table R.8-6
- AF for remaining uncertainties:
- 1
- Justification:
- REACH Guidance Table R.8-6
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
General Population - Hazard via oral route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.5 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 600
- Modified dose descriptor starting point:
- NOAEL
- Value:
- 300 mg/kg bw/day
- Explanation for the modification of the dose descriptor starting point:
- /
- AF for dose response relationship:
- 1
- Justification:
- REACH Guidance Table R.8-6
- AF for differences in duration of exposure:
- 6
- Justification:
- REACH Guidance Table R.8-6-subacute to chronic
- AF for interspecies differences (allometric scaling):
- 4
- Justification:
- REACH Guidance Table R.8-6-rat
- AF for other interspecies differences:
- 2.5
- Justification:
- REACH Guidance Table R.8-6
- AF for intraspecies differences:
- 10
- Justification:
- REACH Guidance Table R.8-6
- AF for the quality of the whole database:
- 1
- Justification:
- REACH Guidance Table R.8-6
- AF for remaining uncertainties:
- 1
- Justification:
- REACH Guidance Table R.8-6
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
General Population - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- no hazard identified
Additional information - General Population
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
